Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
Link to record
Permanent link

Direct link
Publications (10 of 10) Show all publications
Özel, F., White, R. A., Clark, K. D., Indremo, M., Zejlon, I., Rüegg, J. & Papadopoulos, F. C. (2025). Associations between autism, gender dysphoria and gender incongruence: insights from the Swedish Gender Dysphoria Study (SKDS). Psychiatry Research, 351, Article ID 116591.
Open this publication in new window or tab >>Associations between autism, gender dysphoria and gender incongruence: insights from the Swedish Gender Dysphoria Study (SKDS)
Show others...
2025 (English)In: Psychiatry Research, ISSN 0165-1781, E-ISSN 1872-7123, Vol. 351, article id 116591Article in journal (Refereed) Published
Abstract [en]

Background: A higher prevalence of autism spectrum disorder (ASD) and autistic traits among transgender and gender diverse individuals compared to the general population has been reported. However, inconsistent findings and methodological limitations have been noted in the literature. This study aims to investigate the prevalence of ASD diagnoses and autistic traits among individuals with gender dysphoria compared to a cisgender group and to explore associations between autism and self-reported levels of gender incongruence in individuals with gender dysphoria.

Methods: This study is part of the Swedish Gender Dysphoria Study. ASD diagnoses were retrieved from the national patient registers. Autistic traits were assessed using the Ritvo Autism and Asperger Diagnostic Scale-14 (RAADS-14) and Autism Spectrum Quotient (AQ). Gender incongruence was evaluated with the Transgender Congruence Scale. Associations with gender incongruence were examined with linear regression analysis.

Results: Participants with gender dysphoria, regardless of birth-assigned sex, had a higher prevalence of ASD compared with cisgender participants (RR = 7.8; 95 % CI = 3.9, 15.3). The gender dysphoria group also scored higher on both the RAADS-14 (MD = 8.0; 95 % CI = 6.6, 9.6) and AQ (MD = 5.3; 95 % CI = 4.0, 6.6). When stratified by birth-assigned sex, the prevalence of ASD did not differ among participants with gender dysphoria. No association was found between ASD and gender incongruence among individuals with gender dysphoria.

Conclusions: Our findings confirm the high co-occurrence of ASD and gender dysphoria and suggest no difference in gender incongruence between autistic and non-autistic people with gender dysphoria.

Place, publisher, year, edition, pages
Elsevier, 2025
National Category
Psychiatry
Identifiers
urn:nbn:se:uu:diva-553008 (URN)10.1016/j.psychres.2025.116591 (DOI)001511747400001 ()40516315 (PubMedID)
Funder
Region UppsalaMärta och Nicke Nasvells stiftelseForte, Swedish Research Council for Health, Working Life and Welfare, 2021–01968
Available from: 2025-03-20 Created: 2025-03-20 Last updated: 2025-07-03Bibliographically approved
Dahlen, L., Pettersson, K., Berglund, F., Bodlund, O., Dhejne, C., Elfving, M., . . . Papadopoulos, F. (2025). Developing a core outcome set for gender-affirming healthcare in transgender and gender diverse adults in Sweden using the Delphi approach: a study protocol. BMJ Open, 15(7), Article ID e098300.
Open this publication in new window or tab >>Developing a core outcome set for gender-affirming healthcare in transgender and gender diverse adults in Sweden using the Delphi approach: a study protocol
Show others...
2025 (English)In: BMJ Open, E-ISSN 2044-6055, Vol. 15, no 7, article id e098300Article in journal (Refereed) Published
Abstract [en]

Introduction: Despite an increasing amount of research related to gender-affirming treatment (GAT) outcomes among transgender and gender-diverse (TGD) people (ie, people who experience discomfort or distress in the misalignment between their gender and sex assigned at birth) in recent years, the evidence base for current recommendations is suboptimal. One contributing factor is the heterogeneity in the outcomes and outcome measures used. This study seeks to address this challenge by developing a foundational core outcome set (COS) to be used for TGD adults receiving GAT in Sweden.

Methods: Recommendations from the Core Outcome Measures in Effectiveness Trials initiative will be used to address this aim in four phases. Phase 1, an umbrella review of peer-reviewed literature and international guidelines in GAT will be conducted to identify relevant outcomes. In phase 2, we will solicit input from TGD individuals through the review of patient and interest organisations' reports and an anonymous survey to identify outcomes of personal significance. In phase 3, using the Delphi method, 2-3 rounds of assessment will be conducted where researchers, healthcare professionals, policy-makers and TGD adults rate the identified outcomes by perceived importance. In phase 4, a consensus meeting will convene representatives from all stakeholder groups to finalise the COS.

Analysis: The results of this study will consist of a COS for GAT regarding TGD adults in Sweden. Participant survey responses will be evaluated using interpretive analysis to identify core outcomes. During each of the Delphi rounds, Likert-type scale ratings will be aggregated for outcomes to advance or be eliminated in each round.

Ethics and dissemination: The study has received ethical approval by the Swedish Ethical Review Authority (Ume & aring; medicine department, Registration number: 2024-04672-01). The results of this study will be published open-access and disseminated through TGD interest organisations and a Swedish research network for gender dysphoria. Trial registration number COMET registration number 3223.

Place, publisher, year, edition, pages
BMJ Publishing Group Ltd, 2025
Keywords
Health Services for Transgender Persons, Patient Reported Outcome Measures, Protocols & guidelines
National Category
Health Care Service and Management, Health Policy and Services and Health Economy
Identifiers
urn:nbn:se:uu:diva-564324 (URN)10.1136/bmjopen-2024-098300 (DOI)001528426900001 ()40633945 (PubMedID)2-s2.0-105010630750 (Scopus ID)
Funder
Swedish Research Council, 2023-06407
Available from: 2025-08-04 Created: 2025-08-04 Last updated: 2025-08-04Bibliographically approved
Indremo, M. (2025). Epidemiological and clinical aspects in gender dysphoria. (Doctoral dissertation). Uppsala: Acta Universitatis Upsaliensis
Open this publication in new window or tab >>Epidemiological and clinical aspects in gender dysphoria
2025 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

This thesis explores epidemiological and clinical aspects of gender dysphoria (GD), a condition marked by distress or discomfort arising from incongruence between one’s experienced gender and sex assigned at birth.

Study I investigated national trends in GD-diagnoses in Sweden from 2004 to 2015 using national register data. The results revealed a substantial increase in GD diagnoses, particularly among adolescents and young adults. However, the Swedish National Patient Register presents limitations that complicate interpretation, such as low coverage in the early 2000s and variability in diagnostic coding. The study highlights the importance of using clear case definitions in register-based research, as varying criteria yield different prevalence estimates.

Study II examined associations between media coverage and referral patterns to pediatric gender identity services. Using a classification based on public reception of media content as “positive” or “negative”, the study found that negative, widely publicized media coverage was followed by a decline in referral rates lasting up to nine months after publication. These findings suggest that media discourse may influence care-seeking behavior and access to gender-affirming care among youth, underscoring the importance of nuanced reporting in a sensitive clinical field.

Study III assessed the effects of gender-affirming hormone therapy and chest surgery on gender incongruence, gender dysphoria, and body satisfaction, as well as the potential influence of autism on treatment outcomes. Using a target trial emulation (TTE) design with a control group of individuals with GD who had requested but not yet accessed treatment, the study found that those accessing gender-affirming treatment experienced lasting reductions in gender incongruence. Gradual improvements were also observed in gender dysphoria and body satisfaction, although the precision of these estimates decreased over time. There was no evidence that autism significantly influenced treatment outcomes. These results are a further contribution to the evidence base of gender-affirming treatments to alleviate GD; an area where randomized controlled trials are often not feasible.

Study IV involved qualitative interviews with individuals reporting experiences of detransition or changed gender-related healthcare needs. Five main themes were identified, highlighting diverse and evolving experiences shaped by a combination of internal and external factors. The study emphasizes the heterogeneity of this population and the need to respect individual terminology and self-understanding.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2025. p. 74
Series
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 1651-6206 ; 2156
Keywords
Gender dysphoria, gender incongruence, epidemiology, media, gender-affirming treatment, detransition.
National Category
Medical and Health Sciences
Research subject
Medical Science; Psychology
Identifiers
urn:nbn:se:uu:diva-554986 (URN)978-91-513-2495-1 (ISBN)
Public defence
2025-06-13, Gunnesalen, Akademiska sjukhuset, ing 10, Uppsala, 13:00 (English)
Opponent
Supervisors
Available from: 2025-05-23 Created: 2025-04-21 Last updated: 2025-05-23
Clark, K. D., White, R. A., Karamanis, G., Indremo, M., Özel, F., Skalkidou, A., . . . Papadopoulos, F. (2025). Stability After Legal Gender Change Among Adults With Gender Dysphoria. JAMA Network Open, 8(9), Article ID e2527780.
Open this publication in new window or tab >>Stability After Legal Gender Change Among Adults With Gender Dysphoria
Show others...
2025 (English)In: JAMA Network Open, E-ISSN 2574-3805, Vol. 8, no 9, article id e2527780Article in journal (Refereed) Published
Abstract [en]

ImportanceThe number of people seeking treatment for gender dysphoria (GD) has risen in recent decades, yet data remain limited for understanding cases of detransition (ie, the reversal of social, medical, or legal transition). Legal gender change in national registers poses an opportunity to examine legal gender reversals, which may reflect an aspect of the detransition process, while also informing an understanding of the stability after a legal gender change. ObjectiveTo determine the probability of obtaining a legal gender change and its stability over time among people diagnosed with GD in Sweden during a 10-year study period. Design, Setting, and ParticipantsIn this population cohort study using data from Swedish national registers from January 1, 2013, to December 31, 2023, individuals who received their first International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10), diagnosis code for GD during the study period were included. While participants may have received a GD ICD-10 code as youths, legal gender changes only occurred for adults (aged >= 18 years) based on legal requirements during the time of data collection. ExposureGender dysphoria. Main Outcomes and MeasuresLegal gender change and its stability, that is, absence of legal gender reversal, as reported in the registry. Kaplan-Meier survival analysis was used to determine the probability of legal gender change and its stability during a 10-year study period. ResultsA total of 7293 people with a GD diagnosis were included (36 025 person-years). Approximately one-third of the sample (n = 2467) obtained a legal gender change during the study period. The probability of legal gender change at 10 years following diagnosis was 58.3% (95% CI, 56.2%-60.4%). Twenty-one cases of legal gender reversal were identified. The probability of legal gender stability at 10 years following the initial change was 97.7% (95% CI, 96.3%-99.2%), with no differences by sex assigned at birth for either outcome. Conclusions and RelevanceIn this cohort study using national population registry data, a significant proportion of participants with GD in Sweden obtained legal gender change within 10 years of follow-up. Despite significant growth of the population with GD, the probability of legal gender stability during the 10-year study period was high, at almost 98%. These results highlight that legal gender reversal was an infrequent occurrence in a national sample.

Place, publisher, year, edition, pages
American Medical Association (AMA), 2025
National Category
Psychiatry
Identifiers
urn:nbn:se:uu:diva-568248 (URN)10.1001/jamanetworkopen.2025.27780 (DOI)001566859200002 ()40906480 (PubMedID)
Funder
Forte, Swedish Research Council for Health, Working Life and Welfare, 2023-01397
Available from: 2025-10-08 Created: 2025-10-08 Last updated: 2025-10-08Bibliographically approved
Özel, F., Indremo, M., Karamanis, G., Elofsson, U., Beckman, U., Fazekas, A., . . . Papadopoulos, F. C. (2023). Exploring gender dysphoria and related outcomes in a prospective cohort study: protocol for the Swedish Gender Dysphoria Study (SKDS). BMJ Open, 13(4), Article ID e066571.
Open this publication in new window or tab >>Exploring gender dysphoria and related outcomes in a prospective cohort study: protocol for the Swedish Gender Dysphoria Study (SKDS)
Show others...
2023 (English)In: BMJ Open, E-ISSN 2044-6055, Vol. 13, no 4, article id e066571Article in journal (Refereed) Published
Abstract [en]

Introduction There has been a drastic increase in the reported number of people seeking help for gender dysphoria in many countries over the last two decades. Yet, our knowledge of gender dysphoria and related outcomes is restricted due to the lack of high-quality studies employing comprehensive approaches. This longitudinal study aims to enhance our knowledge of gender dysphoria; different aspects will be scrutinised, focusing primarily on the psychosocial and mental health outcomes, prognostic markers and, secondarily, on the underlying mechanisms for its origin. Methods and analysis The Swedish Gender Dysphoria Study is an ongoing multicentre longitudinal cohort study with 501 registered participants with gender dysphoria who are 15 years old or older. Participants at different phases of their clinical evaluation process can enter the study, and the expected follow-up duration is three years. The study also includes a comparison group of 458 age- and county-matched individuals without gender dysphoria. Data on the core outcomes of the study, which are gender incongruence and experienced gender dysphoria, body satisfaction and satisfaction with gender-affirming treatments, as well as other relevant outcomes, including mental health, social functioning and life satisfaction, are collected via web surveys. Two different research visits, before and after starting on gender-affirming hormonal treatment (if applicable), are planned to collect respective biological and cognitive measures. Data analysis will be performed using appropriate biostatistical methods. A power analysis showed that the current sample size is big enough to analyse continuous and categorical outcomes, and participant recruitment will continue until December 2022. Ethics and dissemination The ethical permission for this study was obtained from the Local Ethical Review Board in Uppsala, Sweden. Results of the study will be presented at national and international conferences and published in peer-reviewed journals. Dissemination will also be implemented through the Swedish Gender Dysphoria Study network in Sweden.

Place, publisher, year, edition, pages
BMJ Publishing Group Ltd, 2023
Keywords
Child & adolescent psychiatry, Adult psychiatry, EPIDEMIOLOGY
National Category
Psychiatry
Identifiers
urn:nbn:se:uu:diva-512179 (URN)10.1136/bmjopen-2022-066571 (DOI)001057956000044 ()37076146 (PubMedID)
Funder
Region UppsalaForte, Swedish Research Council for Health, Working Life and Welfare, 2021-01968
Available from: 2023-09-28 Created: 2023-09-28 Last updated: 2025-03-21Bibliographically approved
Indremo, M., Jodensvi, A. C., Arinell, H., Isaksson, J. & Papadopoulos, F. (2022). Association of Media Coverage on Transgender Health With Referrals to Child and Adolescent Gender Identity Clinics in Sweden. JAMA Network Open, 5(2), Article ID e2146531.
Open this publication in new window or tab >>Association of Media Coverage on Transgender Health With Referrals to Child and Adolescent Gender Identity Clinics in Sweden
Show others...
2022 (English)In: JAMA Network Open, E-ISSN 2574-3805, Vol. 5, no 2, article id e2146531Article in journal (Refereed) Published
Abstract [en]

IMPORTANCE Increasing numbers of transgender and gender diverse children and adolescents have been referred to gender identity clinics in Sweden in the past decade, and previous studies have found an association between media attention and referral counts. Whether the tone of media stories is associated with referrals is not yet known.

OBJECTIVE To investigate whether positive or negative media coverage on transgender and gender diverse issues is associated with referral counts to child and adolescent gender identity clinics.

DESIGN, SETTING, AND PARTICIPANTS In this cross-sectional study, referrals counts were collected from all 6 specialized gender identity clinics in Sweden, along with information on referral date, sex assigned at birth, and birth year. Participants were all individuals younger than 19 years, referred to a gender identity clinic between January 1, 2017, and December 31, 2019. Data were analyzed from May 2020 to September 2021.

EXPOSURES Exposures included 3 major media events related to transgender health care in 2019; 1 event was categorized as positive and 2 events were categorized as negative press coverage.

MAIN OUTCOMES AND MEASURES Referral counts before and after each of the 3 major media events were assessed, and the moderating association of sex assigned at birth and age was examined with stratified analyses. Weekly referral counts and trends were assessed with interrupted time series analysis.

RESULTS Among 1784 referrals (359 referrals [21.4%] among individuals aged <13 years; 1034 referrals [72.1%] among individuals assigned female at birth and 401 referrals [27.9%] among individuals assigned male at birth), a negative association between media coverage and referral counts was found for the first of the negative media events. In the 3 months following the event, referrals decreased by 25.4% (95% CI, -31.9% to -18.9%) overall, by 32.2% (95 CI, -41.8% to -22.8%) for individuals assigned female at birth, and by 25.3% (95 CI, -32.4% to -18.3%) for individuals aged 13 to 18 years. In the interrupted time series analysis, a mean weekly decrease of 3% in the referrals was observed in the extended time interval of 39 weeks (incidence rate ratio, 0.97; 95 CI, 0.95 to 0.99). For the other 2 media events, no changes in referral counts or time trends were observed.

CONCLUSIONS AND RELEVANCE These findings suggest that an event of negative media coverage on transgender-specific health care was negatively associated with access to health care for transgender children and adolescents; therefore, nuanced and accurate media coverage, as well as increased awareness of these mechanisms among key stakeholders, is essential.

Place, publisher, year, edition, pages
American Medical Association (AMA)American Medical Association (AMA), 2022
National Category
Public Health, Global Health and Social Medicine Psychiatry
Identifiers
urn:nbn:se:uu:diva-467982 (URN)10.1001/jamanetworkopen.2021.46531 (DOI)000750997000005 ()35107572 (PubMedID)
Available from: 2022-02-21 Created: 2022-02-21 Last updated: 2025-04-21Bibliographically approved
Indremo, M., Jodensvi, A. C., Arinell, H., Isaksson, J. & Papadopoulos, F. (2021). Negative media coverage on transgender health care associated with decreased referrals to child and adolescent Gender Identity Development Services. In: : . Paper presented at 4th EPATH conference: Reconnecting and Redefining Transgender Healthcare, Gothenburg, Sweden, 11-13 August 2021.
Open this publication in new window or tab >>Negative media coverage on transgender health care associated with decreased referrals to child and adolescent Gender Identity Development Services
Show others...
2021 (English)Conference paper, Oral presentation only (Other academic)
National Category
Psychiatry
Identifiers
urn:nbn:se:uu:diva-492971 (URN)
Conference
4th EPATH conference: Reconnecting and Redefining Transgender Healthcare, Gothenburg, Sweden, 11-13 August 2021
Available from: 2023-01-11 Created: 2023-01-11 Last updated: 2023-01-30Bibliographically approved
Indremo, M., White, R., Frisell, T., Cnattingius, S., Skalkidou, A., Isaksson, J. & Papadopoulos, F. C. (2021). Validity of the Gender Dysphoria diagnosis and incidence trends in Sweden: a nationwide register study. Scientific Reports, 11(1), Article ID 16168.
Open this publication in new window or tab >>Validity of the Gender Dysphoria diagnosis and incidence trends in Sweden: a nationwide register study
Show others...
2021 (English)In: Scientific Reports, E-ISSN 2045-2322, Vol. 11, no 1, article id 16168Article in journal (Refereed) Published
Abstract [en]

The aim of this study was to examine the validity of the Gender Dysphoria (GD) diagnoses in the Swedish National Patient Register (NPR), to discuss different register-based definitions of GD and to investigate incidence trends. We collected data on all individuals with registered GD diagnoses between 2001 and 2016 as well as data on the coverage in the NPR. We regarded gender confirming medical intervention (GCMI) as one proxy for a clinically valid diagnosis and calculated the positive predictive value (PPV) for receiving GCMI for increasing number of registered GD diagnoses. We assessed crude and coverage-adjusted time trends of GD during 2004-2015 with a Poisson regression, using assigned sex and age as interaction terms. The PPV for receiving GCMI was 68% for >= 1 and 79% for >= 4 GD-diagnoses. The incidence of GD was on average 35% higher with the definition of >= 1 compared to the definition of >= 4 diagnoses. The incidence of GD, defined as >= 4 diagnoses increased significantly during the study period and mostly in the age categories 10-17 and 18-30 years, even after adjusting for register coverage. We concluded that the validity of a single ICD code denoting clinical GD in the Swedish NPR can be questioned. For future research, we propose to carefully weight the advantages and disadvantages of different register-based definitions according to the individual study's needs, the time periods involved and the age-groups under study.

Place, publisher, year, edition, pages
Springer NatureSpringer Nature, 2021
National Category
Public Health, Global Health and Social Medicine
Identifiers
urn:nbn:se:uu:diva-453362 (URN)10.1038/s41598-021-95421-9 (DOI)000683506200097 ()34373498 (PubMedID)
Available from: 2021-09-16 Created: 2021-09-16 Last updated: 2025-04-21Bibliographically approved
Indremo, M., Forsare, M., Karinsdotter, A., Clark, K. D., Isaksson, J., Westling, S., . . . Papadopoulos, F.Exploring Gender: Insights into Experiences of Detransition and Changes in Transition-related Healthcare Needs.
Open this publication in new window or tab >>Exploring Gender: Insights into Experiences of Detransition and Changes in Transition-related Healthcare Needs
Show others...
(English)Manuscript (preprint) (Other academic)
Abstract [en]

In recent years, the process of gender detransition, discontinuing or reversing a previous gender transition, has become a topic of increasing debate and research interest. This study aimed to explore the experiences of individuals who have discontinued a transition or experienced changes in their transition-related healthcare needs, focusing on how participants describe this process and their related conceptualization of gender. Using purposive sampling, we interviewed 29 adults, including 22 participants assigned female at birth and 7 assigned male at birth. Participants were recruited from detransition networks, LGBTQ organizations, and transgender clinics in Sweden. Approximately half of the participants self-identified as detransitioned, while the others reported changes in their transition-related healthcare needs, without self-identifying as detransitioned. Reflexive thematic analysis was applied to transcribed interviews. We identified five main themes: Self-perception and mental health, societal attitudes on gender, views on the body, body discomfort, and sexuality and romantic intimacy. Participants with different transition trajectories described diverse and complex experiences, characterized by mixed feelings about their transition and detransition processes. Participants' conceptualization of gender emerged as an ongoing, non-linear process, with their experiences rarely fitting neatly within a single theme. These findings underscore the heterogeneity and complexity of transition and detransition experiences, highlighting the importance of individualized care. To better support individuals discontinuing or reversing gender-affirming interventions, further research and tailored clinical guidance are needed.

Keywords
Gender dysphoria, gender detransition
National Category
Basic Medicine
Research subject
Medical Science
Identifiers
urn:nbn:se:uu:diva-554861 (URN)
Available from: 2025-04-16 Created: 2025-04-16 Last updated: 2025-04-21
Indremo, M., Engberg, A., White, R. A., Frisell, T., Isaksson, J., Skalkidou, A. & Papadopoulos, F.Exploring the impact of autism on treatment outcomes following gender-affirming hormonal treatment and top-surgery.
Open this publication in new window or tab >>Exploring the impact of autism on treatment outcomes following gender-affirming hormonal treatment and top-surgery
Show others...
(English)Manuscript (preprint) (Other academic)
Abstract [en]

 Background: Studies comparing outcomes following gender-affirming care between autistic and non-autistic individuals with gender dysphoria (GD) are scarce.Objective: To assess whether gender-affirming hormone therapy (GAHT) and top surgery reduce symptoms of gender incongruence (GI) and GD and enhance body satisfaction, and to examine if these associations are influenced by autistic traits or autism diagnosis.Design: Multicenter longitudinal cohort study within a target trial emulation framework (TTE).Setting: The Swedish Gender Dysphoria Study recruited 514 participants from six specialized gender identity clinics in Sweden between 2016 and 2022, with up to a three-year longitudinal follow-up.Participants:  A subset of 120 participants who received GAHT were compared to 246 participants who had not yet initiated treatment. Additionally, 65 participants who underwent top surgery following GAHT were compared to 134 participants who received GAHT only.Exposure: Data on GAHT and top surgeries were obtained from the National Prescribed Drugs Register, the National Patient Register and supplemented by self-reported survey data.Main outcomes and measures: GI, GD, and body satisfaction were assessed using the Transgender Congruence Scale, Gender Congruence and Life Satisfaction Scale, and Body Image Scale, supplemented by Visual Analogue Scale ratings at baseline and  up to three years post-treatment. We used linear mixed models (LMMs) within a Bayesian estimation framework, with time modeled as a natural cubic spline, retaining all longitudinal outcome data to account for within-person variation.Results: In the GAHT cohort, 67 (56%) among the treated were assigned female at birth, and 59 (49%) exhibited autistic traits. Among those undergoing top surgery, 57 (88%) were assigned female at birth, and 34 (52%) had autistic traits. Posterior estimates from the LMM supported the hypothesis that GAHT yields credible reductions in GI up to 31 months post-treatment, with delayed but credible improvements in GD and body satisfaction, though with increasing uncertainty over time. Top surgery was associated with sustained reductions in GI and early credible improvements in GD and body satisfaction, although posterior uncertainty increased in later follow-up periods. No significant interactions were found between GAHT or top surgery and autistic traits or autism diagnosis for any of the outcomes.Conclusion and relevance: GAHT is associated with improvements in core outcomes, particularly regarding GI, with further benefits following top surgery. No evidence was found to indicate that autistic traits or an autism diagnosis significantly moderate these associations. These results do not support the need for separate guidelines for access to gender-affirming interventions based solely on ASD status.

Keywords
Gender dysphoria, autism, gender-affirmation
National Category
Medical and Health Sciences
Research subject
Medical Science
Identifiers
urn:nbn:se:uu:diva-554975 (URN)
Available from: 2025-04-20 Created: 2025-04-20 Last updated: 2025-04-21
Organisations
Identifiers
ORCID iD: ORCID iD iconorcid.org/0000-0002-6612-7771

Search in DiVA

Show all publications